Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events – is better always good?-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events – is better always good?

Published:2017-06-13 Issue:7 Volume:10 Page:583-586
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Eskazan Ahmet Emre¹^ORCID,Ozmen Deniz¹

Affiliation:

1. Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1339599

Reference19 articles.

1. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

3. Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

4. Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia

5. Reply to K.R. Hoffman

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicenter retrospective study;Cancer;2024-02-05

2. COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic;Biology;2023-04-03

3. Alterations in cellular metabolisms after Imatinib therapy: a review;Medical Oncology;2022-05-16

4. Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia;Expert Review of Hematology;2021-10-20

5. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience;Clinical Lymphoma Myeloma and Leukemia;2021-08